Multicenter study of device-associated infection rates in hospitals of Mongolia: Findings of the International Nosocomial Infection Control Consortium (INICC)

BACKGROUND - To report the results of the International Nosocomial Infection Control Consortium (INICC) multicenter study conducted in Mongolia from September 2013-March 2015.

METHODS - A device-associated health care-associated infection prospective surveillance study in 3 adult intensive care units (ICUs) from 3 hospitals using the U.

S. Centers for Disease Control and Prevention (CDC) and National Healthcare Safety Network (NHSN) definitions and INICC methods.

RESULTS - We documented 467 ICU patients for 2,133 bed days. The central line-associated bloodstream infection (CLABSI) rate was 19. 7 per 1,000 central line days, the ventilator-associated pneumonia (VAP) rate was 43. 7 per 1,000 mechanical ventilator days, and the catheter-associated urinary tract infection (CAUTI) rate was 15. 7 per 1,000 urinary catheter days; all of the rates are higher than the INICC rates (CLABSI: 4. 9; VAP: 16. 5; and CAUTI: 5. 3) and CDC-NHSN rates (CLABSI: 0. 8; VAP: 1. 1; and CAUTI: 1. 3). Device use ratios were also higher than the CDC-NHSN and INICC ratios, except for the mechanical ventilator device use ratio, which was lower than the INICC ratio. Resistance of Staphylococcus aureus to oxacillin was 100%. Extra length of stay was 15. 1 days for patients with CLABSI, 7. 8 days for patients with VAP, and 8. 2 days for patients with CAUTI. Extra crude mortality in the ICUs was 18. 6% for CLABSI, 17. 1% for VAP, and 5. 1% for CAUTI.

CONCLUSIONS - Device-associated health care-associated infection rates and most device use ratios in our Mongolian hospitals' ICUs are higher than the CDC-NSHN and INICC rates.

American journal of infection control. 2015 Dec 09 [Epub ahead of print]

Bat-Erdene Ider, Otgon Baatar, Victor Daniel Rosenthal, Chuluunchimeg Khuderchuluun, Battsetseg Baasanjav, Chuluunbaatar Donkhim, Byambadorj Batsuur, Munhzul Jambiimolom, Suvd-Erdene Purevdorj, Uyanga Tsogtbaatar, Baigalmaa Sodnomdarjaa, Bayasgalan Gendaram, Naranpurev Mendsaikhan, Tsolmon Begzjav, Batsaikhan Narankhuu, Bat-Erdene Ariungerel, Bolormaa Tumendemberel, Pablo Wenceslao Orellano

Intermed Hospital, Ulaanbaatar, Mongolia. , First State Central Hospital, Ulaanbaatar, Mongolia. , International Nosocomial Infection Control Consortium, Buenos Aires, Argentina. First State Central Hospital, Ulaanbaatar, Mongolia. , First State Central Hospital, Ulaanbaatar, Mongolia. , First State Central Hospital, Ulaanbaatar, Mongolia. , First State Central Hospital, Ulaanbaatar, Mongolia. , Second State Central Hospital, Ulaanbaatar, Mongolia. , Second State Central Hospital, Ulaanbaatar, Mongolia. , Second State Central Hospital, Ulaanbaatar, Mongolia. , Second State Central Hospital, Ulaanbaatar, Mongolia. , Second State Central Hospital, Ulaanbaatar, Mongolia. , Intermed Hospital, Ulaanbaatar, Mongolia. , Intermed Hospital, Ulaanbaatar, Mongolia. , Intermed Hospital, Ulaanbaatar, Mongolia. , Intermed Hospital, Ulaanbaatar, Mongolia. , Intermed Hospital, Ulaanbaatar, Mongolia. , International Nosocomial Infection Control Consortium, Buenos Aires, Argentina; Universidad Tecnológica Nacional, Facultad Regional San Nicolás and Consejo Nacional de Investigaciones Científicas y Técnicas, San Nicolás, Argentina.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe